Padagis Appoints Pamela Hoffman as Chief Executive Officer
Industry veteran with more than 20 years of experience to lead the company's next phase of…
Robin BallardApril 1, 2026
Padagis Awarded New York State Department of Health Naloxone Contract
ALLEGAN, Mich., Nov. 12, 2025 /PRNewswire/ -- Padagis® is proud to announce its selection as the supplier…
Robin BallardNovember 12, 2025
Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S.
ALLEGAN, Mich., Oct. 28, 2025 /PRNewswire/ -- Padagis®, a leading generic pharmaceuticals company, has announced an investment of…
Robin BallardOctober 28, 2025
Padagis and The Naloxone Project Partner to Expand Nationwide Access to Lifesaving Naloxone
ALLEGAN, Mich., Sept. 23, 2025 /PRNewswire/ -- Padagis®, a leader in generic pharmaceuticals, today announced a partnership with The…
Robin BallardSeptember 23, 2025
State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis
ALLEGAN, Mich., July 8, 2025 /PRNewswire/ -- Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of…
Robin BallardJuly 8, 2025
Padagis Extends the Shelf-Life of Naloxone HCl Nasal Spray 4 mg to 36 Months
ALLEGAN, Mich., April 2, 2025 /PRNewswire/ -- Padagis®, a leading generic manufacturer, announced today its over-the-counter (OTC) Naloxone…
Robin BallardApril 2, 2025
Padagis Naloxone Now the Lowest Priced Opioid Overdose Treatment Available on Amazon
ALLEGAN, Mich., Feb. 3, 2025 /PRNewswire/ -- Padagis®, a leading generic manufacturer, announced today it is lowering the…
Robin BallardFebruary 3, 2025
Padagis Donates 15K Units of Naloxone to End Overdose to Distribute on College Campus’ Nationwide
ALLEGAN, Mich., Nov. 19, 2024 /PRNewswire/ -- According to recent data from the Centers for Disease Control and…
Robin BallardNovember 19, 2024
